“It came as a surprise that our approach works so well,” Lu said. In preclinical (non-human) studies, the vaccine completely ...

Breakthrough vaccine targets pancreatic cancer cells, showing promise in preclinical trials and paving the way for human testing.

Pancreatic cancer has a five-year survival rate of just 13%, making it the deadliest cancer, according to the American Cancer Society. It typically causes no symptoms until it has already ...

Scientists conducting medical research are facing an existential crisis: Layoffs and budget cuts pushed by President Trump ...

Researchers at Case Western Reserve University and Cleveland Clinic are developing vaccines targeting pancreatic cancer that could eliminate the disease, leaving a patient cancer-free. So far, the ...

Pancreatic cancer vaccines eliminate disease in preclinical studies Pancreatic cancer has a five-year survival rate of just 13%, making it the deadliest cancer, according to the American Cancer ...

A NEW vaccine could cure up to half of all pancreatic cancer cases and may one day wipe out the disease entirely, scientists say. Pancreatic cancer is the deadliest cancer in the world. Some 10,500… ...

Pancreatic cancer has a five-year survival rate of just 13%, making it the deadliest cancer, according to the American Cancer Society.

As part of a clinical trial, the National Center for Tumor Diseases (NCT/UCC) Dresden is now offering patients with ...

Quanyin Hu, a professor in the UW-Madison School of Pharmacy, said the approach could theoretically be applied to any cancer ...

Scientists have developed a new molecule that can deliver powerful immune-activating treatment directly to cancer cells, ...